-
JAMA Network Open
Original Investigation
Oncology
April 22, 2020
Todd A. Pezzi, MD, MBA; David L. Schwartz, MD; Katherine M. W. Pisters, MD; Abdallah S. R. Mohamed, MD; James W. Welsh, MD; Joe Y. Chang, MD, PhD; Zhongxing Liao, MD; Saumil J. Gandhi, MD, PhD; Lauren A. Byers, MD; Bruce D. Minsky, MD; Clifton D. Fuller, MD, PhD; Stephen G. Chun, MD
open access
JAMA Netw Open. 2020; 3(4):e203277. doi: 10.1001/jamanetworkopen.2020.3277
This cohort study examines the association of Medicaid coverage with survival, compared with other insurance statuses, among patients with small cell lung cancer.
-
JAMA Oncology
Original Investigation
November 1, 2019
Dawei Chen, MD; Hari Menon, BS; Vivek Verma, MD; Steven N. Seyedin, MD; Jaffer A. Ajani, MD; Wayne L. Hofstetter, MD; Quynh-Nhu Nguyen, MD; Joe Y. Chang, MD, PhD; Daniel R. Gomez, MD; Arya Amini, MD; Stephen G. Swisher, MD; Mariela A. Blum, MD; Ahmed I. Younes, MD; Hampartsoum B. Barsoumian, PhD; Jeremy J. Erasmus, MD; Jeffrey H. Lee, MD; Manoop S. Bhutani, MD; Kenneth R. Hess, PhD; Bruce D. Minsky, MD; James W. Welsh, MD
free access
JAMA Oncol. 2019; 5(11):1597-1604. doi: 10.1001/jamaoncol.2019.2809
This phase 1/2 single-arm trial examined toxic effects, local control, and overall survival rates after chemoradiotherapy with a simultaneous integrated boost of radiotherapy dose to the gross tumor and nodal disease for patients with unresectable locally advanced esophageal cancer.
-
JAMA Oncology
Original Investigation
June 1, 2019
Quynh-Nhu Nguyen, MD; Stephen G. Chun, MD; Edward Chow, MBBS, PhD; Ritsuko Komaki, MD; Zhongxing Liao, MD; Rensi Zacharia, MD; Bill K. Szeto, BA; James W. Welsh, MD; Stephen M. Hahn, MD; C. David Fuller, MD; Bryan S. Moon, MD; Justin E. Bird, MD; Robert Satcher, MD; Patrick P. Lin, MD; Melenda Jeter, MD; Michael S. O’Reilly, MD; Valerae O. Lewis, MD
free access
has multimedia
JAMA Oncol. 2019; 5(6):872-878. doi: 10.1001/jamaoncol.2019.0192
This randomized phase 2 noninferiority trial assessed the efficacy of high-dose, single-fraction stereotactic radiation therapy vs standard multifraction radiation therapy for pain relief in patients with mostly nonspine bone metastases.
-
JAMA Network Open
Original Investigation
Oncology
August 24, 2018
Eric D. Brooks, MD; Bing Sun, MD; Lei Feng, MS; Vivek Verma, MD; Lina Zhao, MD; Daniel R. Gomez, MD; Zhongxing Liao, MD; Melenda Jeter, MD; Michael O’Reilly, MD; James W. Welsh, MD; Quynh-Nhu Nguyen, MD; Jeremy J. Erasmus, MD; George Eapen, MD; Kamran Ahrar, MD; Mara B. Antonoff, MD; Stephen M. Hahn, MD; John V. Heymach, MD; David C. Rice, MD; Joe Y. Chang, MD
open access
online only
JAMA Netw Open. 2018; 1(4):e181390. doi: 10.1001/jamanetworkopen.2018.1390
This cohort study examines long-term outcomes for patients with isolated local recurrence or isolated regional recurrence after stereotactic ablative radiotherapy for early-stage non–small cell lung cancer with the aim of informing treatment decision making.
-
JAMA Oncology
Brief Report
August 9, 2018
Todd A. Pezzi, MD; David L. Schwartz, MD; Abdallah S. R. Mohamed, MD, MSc; James W. Welsh, MD; Ritsuko U. Komaki, MD; Stephen M. Hahn, MD; Boris Sepesi, MD; Christopher M. Pezzi, MD; Clifton D. Fuller, MD, PhD; Stephen G. Chun, MD
free access
online only
JAMA Oncol. 2018; 4(8):e174504. doi: 10.1001/jamaoncol.2017.4504
This study uses data from the National Cancer Database to estimate utilization rates and factors associated with chemotherapy and radiation therapy delivery for limited-stage small cell lung cancer.